{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:26:47Z","timestamp":1784874407497,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V009346\/1"],"award-info":[{"award-number":["MR\/V009346\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004282","name":"Evelyn Trust","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Leber\u2019s hereditary optic neuropathy (LHON) is a debilitating mitochondrial disease characterised by bilateral painless vision loss. Despite being the most prevalent mitochondrial disorder, the precise pathophysiological mechanisms underlying the penetrance of LHON remain poorly understood. Nuclear modifier genes have been long suspected to affect phenotype-severity, however, specific cellular pathways implicated in the disease penetrance have been only suggested recently. In recent years, autosomal recessive variants in nuclear genes involved in complex I function and metabolic pathways were recognised to cause a typical LHON phenotype. This was proposed as a new autosomal recessive disease mechanism for LHON (arLHON). The association between nuclear variants and the LHON phenotype makes the nuclear pathways disrupted in arLHON the strongest candidates to act as modifiers of mitochondrial LHON (mLHON). In this study we systematically investigated a large cohort of 23 symptomatic and 28 asymptomatic individuals carrying one of the three primary mitochondrial LHON variants. We identified several heterozygous pathogenic nuclear variants amongst the affected individuals that were consistently linked to metabolic and complex I related pathways, mirroring those disrupted in arLHON. Our findings are consistent with the presence of a second hit in specific biological pathways impairing ATP production. We propose that in addition to the primary mitochondrial variants, disruption in these nuclear-encoded pathways drives the clinical manifestation of LHON. Genes involved in the same pathways also emerge as exciting candidates for future association with arLHON. The present study deepens our understanding of LHON\u2019s pathophysiology and provides a new framework for identifying novel disease-modifying targets.<\/jats:p>","DOI":"10.1038\/s41431-025-01860-7","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T13:24:21Z","timestamp":1746797061000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modifier variants in metabolic pathways are associated with an increased penetrance of Leber\u2019s Hereditary Optic Neuropathy"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-1596","authenticated-orcid":false,"given":"Eszter Sara","family":"Arany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0112-5767","authenticated-orcid":false,"given":"Catarina","family":"Olimpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Paramonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-170X","authenticated-orcid":false,"given":"Rita","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"1860_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ajhg.2022.11.013","volume":"110","author":"EC Watson","year":"2023","unstructured":"Watson EC, Davis RL, Ravishankar S, Copty J, Kummerfeld S, Sue CM. Low disease risk and penetrance in Leber hereditary optic neuropathy. Am J Hum Genet. 2023;110:166\u20139. https:\/\/doi.org\/10.1016\/j.ajhg.2022.11.013.","journal-title":"Am J Hum Genet"},{"key":"1860_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40265-020-01428-3","volume":"81","author":"G Amore","year":"2021","unstructured":"Amore G, Romagnoli M, Carbonelli M, Barboni P, Carelli V, La Morgia C. Therapeutic options in hereditary optic neuropathies. Drugs. 2021;81:57\u201386. https:\/\/doi.org\/10.1007\/s40265-020-01428-3.","journal-title":"Drugs"},{"key":"1860_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81\u2013114. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.11.002.","journal-title":"Prog Retin Eye Res"},{"key":"1860_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1080\/02713683.2020.1736307","volume":"45","author":"X Zhao","year":"2020","unstructured":"Zhao X, Zhang Y, Lu L, Yang H. Therapeutic effects of idebenone on leber hereditary optic neuropathy. Curr Eye Res. 2020;45:1315\u201323. https:\/\/doi.org\/10.1080\/02713683.2020.1736307.","journal-title":"Curr Eye Res"},{"key":"1860_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ophtha.2019.11.014","volume":"127","author":"L Poincenot","year":"2020","unstructured":"Poincenot L, Pearson AL, Karanjia R. Demographics of a large international population of patients affected by Leber\u2019s hereditary optic neuropathy. Ophthalmology. 2020;127:679\u201388. https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.014.","journal-title":"Ophthalmology"},{"key":"1860_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.preteyeres.2006.05.002","volume":"25","author":"MY Yen","year":"2006","unstructured":"Yen MY, Wang AG, Wei YH. Leber\u2019s hereditary optic neuropathy: a multifactorial disease. Prog Retin Eye Res. 2006;25:381\u201396. https:\/\/doi.org\/10.1016\/j.preteyeres.2006.05.002.","journal-title":"Prog Retin Eye Res"},{"key":"1860_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/119.5.1481","volume":"119","author":"RM Charlmers","year":"1996","unstructured":"Charlmers RM, Harding AE. A case-control study of Leber\u2019s hereditary optic neuropathy. Brain. 1996;119:1481\u20136. https:\/\/doi.org\/10.1093\/brain\/119.5.1481.","journal-title":"Brain"},{"key":"1860_CR8","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1093\/brain\/awv339","volume":"139","author":"V Carelli","year":"2016","unstructured":"Carelli V, d\u2019Adamo P, Valentino ML, La Morgia C, Ross-Cisneros FN, Caporali L, et al. Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion. Brain. 2016;139:e17. https:\/\/doi.org\/10.1093\/brain\/awv339.","journal-title":"Brain"},{"key":"1860_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/s0002-9394(00)00603-6","volume":"130","author":"JB Kerrison","year":"2000","unstructured":"Kerrison JB, Miller NR, Hsu F, Beaty TH, Maumenee IH, Smith KH, et al. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol. 2000;130:803\u201312. https:\/\/doi.org\/10.1016\/s0002-9394(00)00603-6.","journal-title":"Am J Ophthalmol"},{"key":"1860_CR10","first-page":"1208","volume":"42","author":"FK Jacobi","year":"2001","unstructured":"Jacobi FK, Leo-Kottler B, Mittelviefhaus K, Zrenner E, Meyer J, Pusch CM, et al. Segregation patterns and heteroplasmy prevalence in Leber\u2019s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2001;42:1208\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1860_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/jmg.36.7.505","volume":"36","author":"PF Chinnery","year":"1999","unstructured":"Chinnery PF, Howell N, Andrews RM, Turnbull DM. Mitochondrial DNA analysis: polymorphisms and pathogenicity. J Med Genet. 1999;36:505\u201310.","journal-title":"J Med Genet"},{"key":"1860_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1086\/501236","volume":"78","author":"V Carelli","year":"2006","unstructured":"Carelli V, Achilli A, Valentino ML, Rengo C, Semino O, Pala M, et al. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet. 2006;78:564\u201374. https:\/\/doi.org\/10.1086\/501236.","journal-title":"Am J Hum Genet"},{"key":"1860_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium.","year":"2015","unstructured":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell. 2015;162:516\u201326. https:\/\/doi.org\/10.1016\/j.cell.2015.07.003.","journal-title":"Cell"},{"key":"1860_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/hmg\/5.7.963","volume":"5","author":"MX Guan","year":"1996","unstructured":"Guan MX, Fischel-Ghodsian N, Attardi G. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum Mol Genet. 1996;5:963\u201371. https:\/\/doi.org\/10.1093\/hmg\/5.7.963.","journal-title":"Hum Mol Genet"},{"key":"1860_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1057","volume":"8","author":"CT Pinnaro","year":"2020","unstructured":"Pinnaro CT, Henry T, Major HJ, Parida M, DesJardin LE, Manak JR, et al. Candidate modifier genes for immune function in 22q11.2 deletion syndrome. Mol Genet Genom Med. 2020;8:e1057. https:\/\/doi.org\/10.1002\/mgg3.1057.","journal-title":"Mol Genet Genom Med"},{"key":"1860_CR16","doi-asserted-by":"publisher","first-page":"e0173822","DOI":"10.1371\/journal.pone.0173822","volume":"12","author":"P Trouv\u00e9","year":"2017","unstructured":"Trouv\u00e9 P, G\u00e9nin E, F\u00e9rec C. In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis. PLoS One. 2017;12:e0173822. https:\/\/doi.org\/10.1371\/journal.pone.0173822.","journal-title":"PLoS One"},{"key":"1860_CR17","doi-asserted-by":"publisher","first-page":"e87942","DOI":"10.1371\/journal.pone.0087942","volume":"9","author":"NM Cruz","year":"2014","unstructured":"Cruz NM, Yuan Y, Leehy BD, Baid R, Kompella U, DeAngelis MM, et al. Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease. PLoS One. 2014;9:e87942. https:\/\/doi.org\/10.1371\/journal.pone.0087942.","journal-title":"PLoS One"},{"key":"1860_CR18","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/hmg\/dds102","volume":"21","author":"S Ahmad","year":"2012","unstructured":"Ahmad S, Wang Y, Shaik GM, Burghes AH, Gangwani L. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Hum Mol Genet. 2012;21:2745\u201358. https:\/\/doi.org\/10.1093\/hmg\/dds102.","journal-title":"Hum Mol Genet"},{"key":"1860_CR19","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105364","volume":"39","author":"D Hathazi","year":"2020","unstructured":"Hathazi D, Griffin H, Jennings MJ, Giunta M, Powell C, Pearce SF, et al. Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency. EMBO J. 2020;39:e105364. https:\/\/doi.org\/10.15252\/embj.2020105364.","journal-title":"EMBO J"},{"key":"1860_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13816810701867607","volume":"29","author":"SP Shankar","year":"2008","unstructured":"Shankar SP, Fingert JH, Carelli V, Valentino ML, King TM, Daiger SP, et al. Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet. 2008;29:17\u201324. https:\/\/doi.org\/10.1080\/13816810701867607.","journal-title":"Ophthalmic Genet"},{"key":"1860_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mito.2017.07.004","volume":"36","author":"L Caporali","year":"2017","unstructured":"Caporali L, Maresca A, Capristo M, Del Dotto V, Tagliavini F, Valentino ML, et al. Incomplete penetrance in mitochondrial optic neuropathies. Mitochondrion. 2017;36:130\u20137. https:\/\/doi.org\/10.1016\/j.mito.2017.07.004.","journal-title":"Mitochondrion"},{"key":"1860_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awt343","volume":"137","author":"C Giordano","year":"2014","unstructured":"Giordano C, Iommarini L, Giordano L, Maresca A, Pisano A, Valentino ML, et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy. Brain. 2014;137:335\u201353. https:\/\/doi.org\/10.1093\/brain\/awt343.","journal-title":"Brain"},{"key":"1860_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.mito.2011.03.004","volume":"11","author":"G Hudson","year":"2011","unstructured":"Hudson G, Yu-Wai-Man P, Griffiths PG, Horvath R, Carelli V, Zeviani M, et al. Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON. Mitochondrion. 2011;11:620\u20132. https:\/\/doi.org\/10.1016\/j.mito.2011.03.004.","journal-title":"Mitochondrion"},{"key":"1860_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10384-004-0166-8","volume":"49","author":"K Ishikawa","year":"2005","unstructured":"Ishikawa K, Funayama T, Ohde H, Inagaki Y, Mashima Y. Genetic variants of TP53 and EPHX1 in Leber\u2019s hereditary optic neuropathy and their relationship to age at onset. Jpn J Ophthalmol. 2005;49:121\u20136. https:\/\/doi.org\/10.1007\/s10384-004-0166-8.","journal-title":"Jpn J Ophthalmol"},{"key":"1860_CR25","doi-asserted-by":"publisher","first-page":"13224","DOI":"10.1074\/jbc.RA120.014603","volume":"295","author":"Y Ji","year":"2020","unstructured":"Ji Y, Zhang J, Lu Y, Yi Q, Chen M, Xie S, et al. Complex I mutations synergize to worsen the phenotypic expression of Leber\u2019s hereditary optic neuropathy. J Biol Chem. 2020;295:13224\u201338. https:\/\/doi.org\/10.1074\/jbc.RA120.014603.","journal-title":"J Biol Chem"},{"key":"1860_CR26","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/brain\/awae057","volume":"147","author":"B Blickh\u00e4user","year":"2024","unstructured":"Blickh\u00e4user B, Stenton SL, Neuhofer CM, Floride E, Nesbitt V, Fratter C, et al. Digenic Leigh syndrome on the background of the m.11778G>A Leber hereditary optic neuropathy variant. Brain 2024;147:1967\u201374. https:\/\/doi.org\/10.1093\/brain\/awae057.","journal-title":"Brain"},{"key":"1860_CR27","doi-asserted-by":"publisher","unstructured":"Gerber S, Orssaud C, Kaplan J, Johansson C, Rozet JM MCAT mutations cause nuclear LHON-like optic neuropathy. Genes (Basel). 2021;12. https:\/\/doi.org\/10.3390\/genes12040521.","DOI":"10.3390\/genes12040521"},{"key":"1860_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajhg.2015.09.012","volume":"97","author":"C Angebault","year":"2015","unstructured":"Angebault C, Guichet PO, Talmat-Amar Y, Charif M, Gerber S, Fares-Taie L, et al. Recessive mutations in RTN4IP1 Cause Isolated And Syndromic Optic Neuropathies. Am J Hum Genet. 2015;97:754\u201360. https:\/\/doi.org\/10.1016\/j.ajhg.2015.09.012.","journal-title":"Am J Hum Genet"},{"key":"1860_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jmedgenet-2016-104212","volume":"54","author":"S Gerber","year":"2017","unstructured":"Gerber S, Ding MG, G\u00e9rard X, Zwicker K, Zanlonghi X, Rio M, et al. Compound heterozygosity for severe and hypomorphic NDUFS2 mutations cause non-syndromic LHON-like optic neuropathy. J Med Genet. 2017;54:346\u201356. https:\/\/doi.org\/10.1136\/jmedgenet-2016-104212.","journal-title":"J Med Genet"},{"key":"1860_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/jmedgenet-2021-108235","volume":"59","author":"S Kieninger","year":"2022","unstructured":"Kieninger S, Xiao T, Weisschuh N, Kohl S, R\u00fcther K, Kroisel PM, et al. DNAJC30 disease-causing gene variants in a large Central European cohort of patients with suspected Leber\u2019s hereditary optic neuropathy and optic atrophy. J Med Genet. 2022;59:1027\u201334. https:\/\/doi.org\/10.1136\/jmedgenet-2021-108235.","journal-title":"J Med Genet"},{"key":"1860_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/mdc3.13398","volume":"9","author":"F Magrinelli","year":"2022","unstructured":"Magrinelli F, Cali E, Braga VL, Yis U, Tomoum H, Shamseldin H, et al. Biallelic loss-of-function NDUFA12 variants cause a wide phenotypic spectrum from leigh\/leigh-like syndrome to isolated optic atrophy. Mov Disord Clin Pr. 2022;9:218\u201328. https:\/\/doi.org\/10.1002\/mdc3.13398.","journal-title":"Mov Disord Clin Pr"},{"key":"1860_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ajhg.2009.03.003","volume":"84","author":"S Hanein","year":"2009","unstructured":"Hanein S, Perrault I, Roche O, Gerber S, Khadom N, Rio M, et al. TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy. Am J Hum Genet. 2009;84:493\u20138. https:\/\/doi.org\/10.1016\/j.ajhg.2009.03.003.","journal-title":"Am J Hum Genet"},{"key":"1860_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/jmg-2023-109340","volume":"61","author":"C Fiorini","year":"2023","unstructured":"Fiorini C, Degiorgi A, Cascavilla ML, Tropeano CV, La Morgia C, Battista M, et al. Recessive MECR pathogenic variants cause an LHON-like optic neuropathy. J Med Genet. 2023;61:93\u2013101. https:\/\/doi.org\/10.1136\/jmg-2023-109340.","journal-title":"J Med Genet"},{"key":"1860_CR34","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/jmedgenet-2014-102532","volume":"51","author":"MD Metodiev","year":"2014","unstructured":"Metodiev MD, Gerber S, Hubert L, Delahodde A, Chretien D, G\u00e9rard X, et al. Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy. J Med Genet. 2014;51:834\u20138. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102532.","journal-title":"J Med Genet"},{"key":"1860_CR35","doi-asserted-by":"publisher","unstructured":"Laurie S, Piscia D, Matalonga L, Corv\u00f3 A, Fern\u00e1ndez-Callejo M, Garcia-Linares C, et al. The RD\u2010connect genome\u2010phenome analysis platform: accelerating diagnosis, research, and gene discovery for rare diseases. Hum Mutat. Published online February 17, 2022. https:\/\/doi.org\/10.1002\/humu.24353.","DOI":"10.1002\/humu.24353"},{"key":"1860_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"key":"1860_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"1860_CR38","unstructured":"Durkie M, Cassidy EJ, Berry I, Owens M, Turnbull C, Scott RH, et al. ACGs best practice guidelines for variant classification in rare disease 2024. Assoc Clin Genomic Sci. 2024. https:\/\/www.acgs.uk.com\/media\/12533\/uk-practice-guidelines-for-variant-classification-v12-2024.pdf."},{"key":"1860_CR39","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49:D1541\u20137. https:\/\/doi.org\/10.1093\/nar\/gkaa1011.","journal-title":"Nucleic Acids Res"},{"key":"1860_CR40","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"key":"1860_CR41","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49:D545\u201351. https:\/\/doi.org\/10.1093\/nar\/gkaa970.","journal-title":"Nucleic Acids Res"},{"key":"1860_CR42","doi-asserted-by":"publisher","unstructured":"Cheng HC, Chi SC, Liang CY, Yu JY, Wang AG. Candidate modifier genes for the penetrance of Leber\u2019s hereditary optic neuropathy. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms231911891.","DOI":"10.3390\/ijms231911891"},{"key":"1860_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1107\/S205225252000696X","volume":"7","author":"GA Bezerra","year":"2020","unstructured":"Bezerra GA, Foster WR, Bailey HJ, Hicks KG, Sauer SW, Dimitrov B, et al. Crystal structure and interaction studies of human DHTKD1 provide insight into a mitochondrial megacomplex in lysine catabolism. IUCrJ. 2020;7:693\u2013706. https:\/\/doi.org\/10.1107\/S205225252000696X.","journal-title":"IUCrJ"},{"key":"1860_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molcatb.2009.05.001","volume":"61","author":"MS Patel","year":"2009","unstructured":"Patel MS, Korotchkina LG, Sidhu S. Interaction of E1 and E3 components with the core proteins of the human pyruvate dehydrogenase complex. J Mol Catal B Enzym. 2009;61:2\u20136. https:\/\/doi.org\/10.1016\/j.molcatb.2009.05.001.","journal-title":"J Mol Catal B Enzym"},{"key":"1860_CR45","doi-asserted-by":"publisher","first-page":"18152","DOI":"10.1074\/jbc.M109.014118","volume":"284","author":"G Fiermonte","year":"2009","unstructured":"Fiermonte G, Paradies E, Todisco S, Marobbio CMT, Palmieri F. A novel member of solute carrier family 25 (SLC25A42) is a transporter of coenzyme A and adenosine 3\u2019,5\u2019-diphosphate in human mitochondria. J Biol Chem. 2009;284:18152\u20139. https:\/\/doi.org\/10.1074\/jbc.M109.014118.","journal-title":"J Biol Chem"},{"key":"1860_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajhg.2016.11.014","volume":"100","author":"S Ait-El-Mkadem","year":"2017","unstructured":"Ait-El-Mkadem S, Dayem-Quere M, Gusic M, Chaussenot A, Bannwarth S, Fran\u00e7ois B, et al. Mutations in MDH2, encoding a Krebs cycle enzyme, cause early-onset severe encephalopathy. Am J Hum Genet. 2017;100:151\u20139. https:\/\/doi.org\/10.1016\/j.ajhg.2016.11.014.","journal-title":"Am J Hum Genet"},{"key":"1860_CR47","doi-asserted-by":"publisher","unstructured":"Ni Y, Hagras MA, Konstantopoulou V, Mayr JA, Stuchebrukhov AA, Meierhofer D. Mutations in NDUFS1 cause metabolic reprogramming and disruption of the electron transfer. Cells. 2019;8. https:\/\/doi.org\/10.3390\/cells8101149.","DOI":"10.3390\/cells8101149"},{"key":"1860_CR48","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/hmg\/ddt521","volume":"23","author":"J Nouws","year":"2014","unstructured":"Nouws J, Te Brinke H, Nijtmans LG, Houten SM. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies. Hum Mol Genet. 2014;23:1311\u20139. https:\/\/doi.org\/10.1093\/hmg\/ddt521.","journal-title":"Hum Mol Genet"},{"key":"1860_CR49","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ymgme.2010.12.005","volume":"102","author":"M He","year":"2011","unstructured":"He M, Pei Z, Mohsen AW, Watkins P, Murdoch G, Van Veldhoven PP, et al. Identification and characterization of new long chain acyl-CoA dehydrogenases. Mol Genet Metab. 2011;102:418\u201329. https:\/\/doi.org\/10.1016\/j.ymgme.2010.12.005.","journal-title":"Mol Genet Metab"},{"key":"1860_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41589-023-01452-w","volume":"20","author":"I Park","year":"2024","unstructured":"Park I, Kim KE, Kim J, Kim AK, Bae S, Jung M, et al. Mitochondrial matrix RTN4IP1\/OPA10 is an oxidoreductase for coenzyme Q synthesis. Nat Chem Biol. 2024;20:221\u201333. https:\/\/doi.org\/10.1038\/s41589-023-01452-w.","journal-title":"Nat Chem Biol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01860-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:46:00Z","timestamp":1769769960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01860-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01860-7","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study utilized a large pre-existing database containing de-identified participant data. As the dataset did not include any personal identifiers and was available to registered users, ethical approval was not required to conduct this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}